HACKENSACK, N.J. (AP) — HACKENSACK, N.J. (AP) — Protalix BioTherapeutics Inc. (PLX) on Tuesday reported profit of $4 million in its third quarter.

On a per-share basis, the Hackensack, New Jersey-based company said it had net income of 5 cents.

The drug developer posted revenue of $21.9 million in the period.

Protalix expects full-year revenue in the range of $78 million to $83 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PLX at https://www.zacks.com/ap/PLX